MARKET

CYRX

CYRX

Cryoport
NASDAQ

Real-time Quotes | Nasdaq Last Sale

43.98
+1.17
+2.73%
After Hours: 44.37 +0.39 +0.89% 17:38 10/23 EDT
OPEN
43.15
PREV CLOSE
42.81
HIGH
44.08
LOW
42.43
VOLUME
213.50K
TURNOVER
--
52 WEEK HIGH
60.82
52 WEEK LOW
13.01
MARKET CAP
1.71B
P/E (TTM)
-69.5556
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Gamco Investors, Jana Partners Make Activist Moves
Gamco Investors increased its stake in language-education company Rosetta Stone. Jana Partners bought more shares of government IT-services firm Perspecta.
Barrons.com · 10/16 20:15
Forecast: Analysts Think Cryoport, Inc.'s (NASDAQ:CYRX) Business Prospects Have Improved Drastically
Shareholders in Cryoport, Inc. (NASDAQ:CYRX) may be thrilled to learn that the analysts have just delivered a major...
Simply Wall St. · 10/15 14:54
At US$51.37, Is It Time To Put Cryoport, Inc. (NASDAQ:CYRX) On Your Watch List?
Cryoport, Inc. (NASDAQ:CYRX), might not be a large cap stock, but it saw a significant share price rise of over 20% in...
Simply Wall St. · 10/08 13:04
Cryoport: A Levered Refrigerator Manufacturer Trading At A Tech Multiple, $10 Price Target
Cryoport is the amalgamation of three separate slow growth businesses wrapped in the auspices of the COVID-19 vaccine effort.The company is a now net debt and has little to no organic growth.I am hard pressed to find intrinsic value over $6.Even when adding in one time COVID benefits the stock shouldn’t be worth more then $10/share, the sharecount used by the sellside is also incomplete and undercounts shares by 12%.Pfizer and the CDC have clarified that high capacity refrigeration is NOT necessary for COVID vaccine distribution.
Seekingalpha · 10/08 12:35
Chart Industries: Healthcare Hints
Chart Industries is exiting the regulated medical business by selling to Cryoport.This is the second sale of healthcare businesses and may indicate a market top for these businesses.Chart will focus on the industry bulk core business.The sale should cut long-term debt to about half of current levels.Fast growth is likely to resume after this sale.
Seekingalpha · 10/02 08:13
Cryoport Completes Acquision Of MVE Biological Solutions And CRYOPDP
Cryoport Completes Acquisitions of MVE Biological Solutions and CRYOPDP NASHVILLE, Tenn., Oct. 1, 2020 /PRNewswire/ --Cryoport, Inc. (NASDAQ:CYRX) ("Cryoport" or the "Company"), the life
Benzinga · 10/01 16:51
Cryoport Completes Acquisitions of MVE Biological Solutions and CRYOPDP
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), the life sciences industry's preeminent partner for temperature-controlled supply chain solutions, today announced it has completed the acquisitions of MVE Biological Solutions ("MVE"), a global leader in manufactured
PR Newswire · 10/01 16:49
Chart Industries Expands Liquid Hydrogen and LNG Business with Strategic Agreements
Chart Industries, Inc. (“Chart”) (NASDAQ: GTLS) today completed the previously announced divestiture of its cryobiological products business (MVE Biological Products) to Cryoport, Inc. (“Cryoport”) (NASDAQ: CYRX) for $320 million in cash. On September 30, 2020, Chart and Plug Power Inc. (NASDAQ: PLUG
GlobeNewswire · 10/01 15:38
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CYRX. Analyze the recent business situations of Cryoport through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CYRX stock price target is 52.17 with a high estimate of 66.00 and a low estimate of 42.00.
EPS
Institutional Holdings
Institutions: 184
Institutional Holdings: 41.84M
% Owned: 107.89%
Shares Outstanding: 38.78M
TypeInstitutionsShares
Increased
44
3.30M
New
51
3.48M
Decreased
44
8.69M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Air Freight & Courier Services
+0.19%
Freight & Logistics Services
+0.31%
Key Executives
Chairman/President/Chief Executive Officer/Director
Jerrell Shelton
Chief Financial Officer/Treasurer/Secretary
Robert Stefanovich
Lead Director/Independent Director
Richard Berman
Director
Daniel Hancock
Director
Ram Jagannath
Independent Director
Robert Hariri
Independent Director
Richard Schwalm
Independent Director
Ramkumar Mandalam
Independent Director
Edward Zecchini
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CYRX
Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services the Company enable its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of CryoPort Inc stock information, including NASDAQ:CYRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CYRX stock methods without spending real money on the virtual paper trading platform.